Stock prices of major new drug developing companies increased by 32.8% this year

On September 4, according to the report of Shinhan Investment & Securities, stock prices of major new drug developing companies increased by 32.8% this year.

In case of Genexine whose largest shareholder changed to Handok in March, is recording the highest stock growth rate this year among new drug developing companies, due to the expect for improving financial stability. It is analyzed that V...